SCHEMBL3206907

SCHEMBL3206907

O=C(O)C1=C(c2ccccc2)CN(Cc2ccccc2)CC1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 1/20 0.48
CHRM2 P08172 5/20 0.46
CHRM4 P08173 5/20 0.46
CHRM5 P08912 5/20 0.46
CHRM1 P11229 5/20 0.46
CHRM3 P20309 5/20 0.46
HDAC4 P56524 1/20 0.44
KCNH2 Q12809 1/20 0.44
HDAC1 Q13547 1/20 0.44
SIGMAR1 Q99720 1/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
PTPN2 P17706 1/20 0.44
PTPN1 P18031 1/20 0.44
ALDH1A1 P00352 2/20 0.43
HPGD P15428 1/20 0.43
SLC6A5 Q9Y345 1/20 0.43
PNMT P11086 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4103430 0.99 CHRM2 (0.48) ADORA1CHRM2CHRM4CHRM5CHRM1
SCHEMBL2998828 0.92 SIGMAR1 (0.49) ADORA1CHRM5CHRM1SIGMAR1MEN1
SCHEMBL3008719 0.91 MEN1 (0.46) CHRM5CHRM1SIGMAR1MEN1KMT2A
Hydrochloric Acid SCHEMBL1973926 0.90 KDM4E (0.47) CHRM5CHRM1SIGMAR1MEN1KMT2A
SCHEMBL8363142 0.88 CHRM5 (0.55) ADORA1CHRM2CHRM4CHRM5CHRM1
SCHEMBL19893491 0.87 L3MBTL1 (0.50) CHRM2SIGMAR1PTPN1ALDH1A1
SCHEMBL14563112 0.87 SIGMAR1 (0.53) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL1751581 0.86 HDAC4 (0.44) CHRM2CHRM4CHRM5CHRM1CHRM3
Hydrochloric Acid SCHEMBL4092844 0.85 SIGMAR1 (0.47) ADORA1CHRM2CHRM3SIGMAR1MEN1
SCHEMBL3016371 0.85 POLB (0.47) ADORA1CHRM4SIGMAR1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8324248-B2 Piperidine derivatives as NK3 receptor antagonists HOFFMANN-LA ROCHE INC. (US) 2012-12-04 US disclosed
US-20100197697-A1 PIPERIDINE DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2010-08-05 US disclosed
US-20100035865-A1 Sulfonamides and Pharmaceutical Compositions Thereof PFIZER INC 2010-02-11 US disclosed
US-7247641-B2 Compounds, derivatives, compositions, preparation and uses MGI GP, INC. (US) 2007-07-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100035865-A1 Sulfonamides and Pharmaceutical Compositions Thereof STS, SULT2A1, SULT1A1 ADORA1 2574/4885CHRM2 4097/4885CHRM4 4343/4885
US-20100197697-A1 PIPERIDINE DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS OPRK1, OPRM1, OPRL1 ADORA1 35/4885CHRM2 126/4885CHRM4 177/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.